Mark Glickman

Mark Glickman is a seasoned executive with over 30 years of experience in transforming clinical companies into commercial successes. They currently serve as President and CEO of BioFlorida, Inc. and as a member of the Board of Directors for both Otsuka Precision Health, Inc. and NeuroBo Pharmaceuticals, Inc. Glickman previously held senior roles at companies such as Kos Pharmaceuticals and Bristol-Myers Squibb, where they drove significant revenue growth and launched multiple successful products, including groundbreaking licensing deals in the pharmaceutical industry. They earned an MBA in Finance and International Management from New York University's Leonard N. Stern School of Business and a BA from the State University of New York at Oswego.